reduced receivables and lower than planned capital spend. On the Use of Resources metric, the Trust had maintained a rating of a rating of indicated lowest risk and “3” (where “1” “4” indicated highest risk) due to agency costs being higher than planned spend and the NHS Improvement agency ceiling. b CIP delivery for the month was £0.1 million behind plan and £0.5 million below target. c The Board noted the report. BOD Standing Financial Instructions (SFIs) 111/17 a The Director of Finance presented the report BOD 83/2017 which summarised review of the SFIs and proposed changes. Alyson Coates confirmed that the Audit Committee had reviewed the proposed changes to the SFIs out-of-session and recommended them to the Board. b The Board APPROVED the revised SFIs. BOD Medical Appraisal and Revalidation Report 112/17 a The Medical Director presented the report BOD 84/2017 on the annual medical appraisal of doctors and the revalidation figures for the Trust. He noted the limited resource available to maintain satisfactory medical revalidation and the impact upon capacity for 2017/18 of a number of retirements and resignations of appraisers. The Director of Nursing and Clinical Standards noted that although medical revalidation resource may be limited, this still compared favourably to the position of nurses who were also subject to revalidation processes. b Alyson Coates asked whether the Trust was responsible for revalidating doctors in the OOH service or locum doctors. The Medical Director replied that this would be done through locum agencies or NHS England, not the Trust. c The Board noted the report. BOD Corporate Governance Self-Certification and other 113/17 certifications a The Director of Corporate Affairs & Company Secretary
b c reduced receivables and lower than planned capital spend. On the Use of Resources metric, the Trust had maintained a rating of “3” (where a rating of “1” indicated lowest risk and “4” indicated highest risk) due to agency costs being higher than planned spend and the NHS Improvement agency ceiling. CIP delivery for the month was £0.1 million behind plan and £0.5 million below target. The Board noted the report. BOD 111/17 a b Standing Financial Instructions (SFIs) The Director of Finance presented the report BOD 83/2017 which summarised review of the SFIs and proposed changes. Alyson Coates confirmed that the Audit Committee had reviewed the proposed changes to the SFIs out-of-session and recommended them to the Board. The Board APPROVED the revised SFIs. BOD 112/17 a b c Medical Appraisal and Revalidation Report The Medical Director presented the report BOD 84/2017 on the annual medical appraisal of doctors and the revalidation figures for the Trust. He noted the limited resource available to maintain satisfactory medical revalidation and the impact upon capacity for 2017/18 of a number of retirements and resignations of appraisers. The Director of Nursing and Clinical Standards noted that although medical revalidation resource may be limited, this still compared favourably to the position of nurses who were also subject to revalidation processes. Alyson Coates asked whether the Trust was responsible for revalidating doctors in the OOH service or locum doctors. The Medical Director replied that this would be done through locum agencies or NHS England, not the Trust. The Board noted the report. BOD 113/17 a Corporate Governance Self-Certification and other certifications The Director of Corporate Affairs & Company Secretary
90i_BOD_Mins_28-June-2017-v.1c.docx